Innovation

Learn about the revolutionary work they’re both doing in the field of neurodegenerative disease that could prove important in fighting often-fatal conditions.

A study of women, by women. We’re talking about the Imbokodo trial, which is evaluating an investigational HIV vaccine in sub-Saharan Africa. As the study hits a key milestone, we sat down with South African physician and scientist Glenda Gray, who’s at the helm of the groundbreaking trial.

Creative recycling initiatives. Global sustainability pledges. Innovative products. In honor of Earth Day, we’re taking a look at how the company is helping to increase recycling, reduce environmental impact and boost sustainability.

A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.

The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.

It’s been 30 years since the first World AIDS Day was recognized. Jens Van Roey, M.D., shares how a fateful diagnosis coincidentally that same year transformed him from a humble physician into a tireless champion for those afflicted with the disease.

For this season of giving, we take a look at a special, 25-year partnership between Mercy Ships and Johnson & Johnson that’s leaving hope, healing and resilience in its wake.

The company has secured a top ranking on the biennial report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the fourth consecutive time.

This first-of-its-kind innovation has a dynamic photochromic filter that responds to changing light conditions.

It isn’t just music superstars who attend the annual event taking place in New York City and South Africa this year. Johnson & Johnson’s Chief Scientific Officer, Dr. Paul Stoffels, is on the lineup, too. He shares his personal story of why he’s so dedicated to global public health—and how the company is working to prevent HIV infections through an investigational vaccine.